13D/13G Filings - Avoro Capital Advisors LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-11
10:03 am
Purchase
2021-12-3113GCymaBay Therapeutics, Inc.
CBAY
Avoro Capital Advisors LLC12,800,000
14.700%
2,500,000increase
(+24.27%)
Filing
History
2022-02-11
10:02 am
Purchase
2021-12-3113GUnited Therapeutics Corporation
UTHR
Avoro Capital Advisors LLC3,035,000
6.700%
185,000increase
(+6.49%)
Filing
History
2022-02-11
10:01 am
Sale
2021-12-3113GAdverum Biotechnologies, Inc.
ADVM
Avoro Capital Advisors LLC695,000
7.100%
-105,000decrease
(-13.12%)
Filing
History
2022-02-11
10:01 am
Purchase
2021-12-3113GMarinus Pharmaceuticals, Inc.
MRNS
Avoro Capital Advisors LLC3,235,000
8.800%
2,858increase
(+0.09%)
Filing
History
2022-02-11
10:01 am
Purchase
2021-12-3113GMirati Therapeutics, Inc.
MRTX
Avoro Capital Advisors LLC5,075,000
9.200%
540,000increase
(+11.91%)
Filing
History
2022-02-11
10:00 am
Purchase
2021-12-3113GXenon Pharmaceuticals Inc.
XENE
Avoro Capital Advisors LLC4,985,000
9.700%
2,185,000increase
(+78.04%)
Filing
History
2021-11-24
3:48 pm
Sale
2021-11-2213DAcceleron Pharma Inc.
XLRN
Avoro Capital Advisors LLC0
0.000%
-4,476,100decrease
(Position Closed)
Filing
History
2021-10-05
12:30 pm
Purchase
2021-09-3013DAcceleron Pharma Inc.
XLRN
Avoro Capital Advisors LLC4,476,100
7.300%
4,476,100increase
(New Position)
Filing
History
2021-08-30
5:27 pm
Purchase
2021-08-2613DWhitehawk Therapeutics Inc
WHWK
Avoro Capital Advisors LLC2,211,752
10.700%
2,211,752increase
(New Position)
Filing
History
2021-06-04
08:30 am
Purchase
2021-05-2713DAerpio Pharmaceuticals, Inc.
ARPO
Avoro Capital Advisors LLC300,000
9.500%
300,000increase
(New Position)
Filing
History
2021-02-12
08:14 am
Purchase
2020-12-3113GMarinus Pharmaceuticals, Inc.
MRNS
Avoro Capital Advisors LLC3,232,142
9.090%
3,232,142increase
(New Position)
Filing
History
2021-02-12
08:14 am
Purchase
2020-12-3113GXenon Pharmaceuticals Inc.
XENE
Avoro Capital Advisors LLC2,800,000
8.000%
400,000increase
(+16.67%)
Filing
History
2021-02-12
08:13 am
Sale
2020-12-3113GKaryopharm Therapeutics Inc.
KPTI
Avoro Capital Advisors LLC0
0.000%
-393,333decrease
(Position Closed)
Filing
History
2021-02-12
08:13 am
Sale
2020-12-3113GCue Biopharma, Inc.
CUE
Avoro Capital Advisors LLC452,500
1.500%
-1,417,500decrease
(-75.80%)
Filing
History
2021-02-12
08:12 am
Sale
2020-12-3113GAthenex, Inc.
ATNX
Avoro Capital Advisors LLC18,625
0.400%
-244,447decrease
(-92.92%)
Filing
History
2021-02-12
08:11 am
Sale
2020-12-3113GAlimera Sciences, Inc.
ALIM
Avoro Capital Advisors LLC0
0.000%
-415,999decrease
(Position Closed)
Filing
History
2021-02-12
08:11 am
Purchase
2020-12-3113GPMV Pharmaceuticals, Inc.
PMVP
Avoro Capital Advisors LLC2,350,267
5.300%
2,350,267increase
(New Position)
Filing
History
2021-02-12
08:10 am
Purchase
2020-12-3113GTherapeutics Acquisition Corp.
RACA
Avoro Capital Advisors LLC1,000,000
7.100%
1,000,000increase
(New Position)
Filing
History
2021-02-12
08:09 am
Purchase
2020-12-3113GTrillium Therapeutics Inc.
TRIL
Avoro Capital Advisors LLC5,800,000
5.700%
5,800,000increase
(New Position)
Filing
History
2021-02-12
08:09 am
Purchase
2020-12-3113GKura Oncology, Inc.
KURA
Avoro Capital Advisors LLC4,000,000
6.200%
4,000,000increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, 5, Next